News
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces it has engaged Enclave Capital LLC ("Enclave") to act as an agent, in collaboration with D12 Capital Markets ...
Black and Latino patients were less likely to be prescribed oral antivirals for COVID-19 compared with white patients. Barriers such as limited access to clinicians and home tests may drive a ...
That reflects the scientifically debunked notion that children today get too many vaccinations, somehow overwhelming their immune system. Doctors say improved vaccine technology means kids today are ...
An antigen is any protein or molecule that your immune system recognizes as foreign. When you get a vaccine, the antigens in it teach your immune system to identify and fight specific diseases.
Article citations More>> Smitt, P.A.E.S., Manley, G.T. and Posner, J.B. (1995) Immunization with the Paraneoplastic Encephalomyelitis Antigen HuD Does Not Cause Neurologic Disease in Mice. Neurology, ...
The human immune system consists of a large number of T cells capable of recognizing and responding to antigens derived from various sources. The development of peptide-major histocompatibility (p/MHC ...
Antigenic variation is a key mechanism by which pathogens evade the immune system. New research has shown how trypanosomes change their antigen expression.
Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful in hematologic malignancies, presents a promising avenue for treating solid tumors, including CRC. This review explores the ...
IRVINE, Calif., Aug. 7, 2024 /PRNewswire/ -- PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells ...
The bacteria-based intracellular delivering (ID) system uses a non-toxic form of Salmonella that releases a drug, in this case a vaccine antigen, after it's inside a solid-tumor cancer cell.
Prostate-specific Membrane Antigen Reporting and Data System (PSMA-RADS) was introduced for standardized reporting, and PSMA-RADS version 1.0 allows classification of lesions based on their likelihood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results